Objective  To explore the clinical efficacy and safety of Xuefu Zhuyu decoction as an adjuvant chemotherapy in patients with advanced cervical cancer.

Methods  This study recruited advanced cervical cancer patients who underwent TP regimen (paclitaxel+cisplatin) chemotherapy in Luzhou District People's Hospital in Changzhi City from January 2019 to January 2021. According to the random number table method, patients with advanced cervical cancer were divided into a control group (treated with TP regimen) and an test group (treated with TP regimen combined with Xuefu Zhuyu decoction). The serum tumor marker levels (carcinoembryonic antigen, squamous cell carcinoma antigen and carbohydrate antigen 125), traditional Chinese medicine syndrome scores and clinical efficacy [objective response rate, disease control rate and overall survival time] between two groups of patients were observed and compared. The occurrence of adverse drug reactions was assessed  according to the Common Terminology Standard for Adverse Events (CTCAE 4.03).

Results  A total of 92 cases of advanced cervical cancer were included in this study, with 46 cases in each group. Before treatment, there was no significant statistical difference in the serum tumor marker levels and traditional Chinese medicine syndrome scores between the control group and the test group with advanced cervical cancer (P>0.05). After treatment, the serum tumor marker levels and traditional Chinese medicine syndrome scores in the test group and the control group significantly decreased compared to before (P<0.05), and they were significantly lower in the test group than those in the control group (P<0.05). In terms of clinical efficacy, there was no significant difference in objective response rate between two groups (P>0.05), while the disease control rate and median overall survival time of the test group were significantly higher than those of the control group (P<0.05). In terms of safety, no fatal adverse events were observed, and most adverse events were mild and controllable. In addition, there was no significant difference in the incidence of nausea and vomiting, anemia, thrombocytopenia and renal dysfunction between two groups (P>0.05), while the incidence of leukopenia and liver function injury in the test group were significantly lower than those in the control group (P<0.05).

Conclusion  Xuefu Zhuyu decoction can significantly improve the efficacy of chemotherapy patients with advanced cervical cancer, reduce serum tumor marker expression levels, improve traditional Chinese medicine syndrome scores, increase disease control rate, prolong overall survival, and has high safety.

1.王秋梅, 刘晓庆, 孙姗姗, 等. 血清HMGB1和SAA对宫颈癌术后发生预后不良的诊断价值[J]. 检验医学与临床, 2023, 20(6): 797-800, 804. [Wang QM, Liu XQ, Sun SS, et al. The diagnostic value of serum HMGB1 and SAA for poor prognosis after cervical cancer surgery[J]. Laboratory Medicine and Clinical, 2023, 20(6): 797-800, 804.] DOI: 10.3969/j. issn.1672-9455.2023.06.018.

2.Zhong L, Li KM, Song L, et al. The effect of consolidation chemotherapy after concurrent chemoradiation on the prognosis of locally advanced cervical cancer: a systematic review and meta-analysis[J]. J Obstet Gynaecol, 2022, 42(5): 830-837. DOI: 10.1080/01443615.2021.2012437.

3.王朋丽, 牛海燕, 宋云焕, 等. 新辅助化疗联合放疗对宫颈癌患者临床疗效及预后的影响[J]. 癌症进展, 2021, 19(5): 522-524. [Wang PL, Niu HY, Song YH, et al. The effect of neoadjuvant chemotherapy combined with radiotherapy on the clinical efficacy and prognosis of patients with cervical cancer [J]. Cancer Progress, 2021, 19(5): 522-524.] DOI: 10.11877/j.issn.1672-1535. 2021.19.05.23.

4.贺迎霞,张庆田, 王冬梅, 等. 重组人干扰素α-2b凝胶联合ALA-PDT疗法对尖锐湿疣患者血清T细胞亚群、GM-CSF水平变化及生活质量的影响[J]. 中国性 科学, 2019, 28(1): 127-131. [He YX, Zhang QT, Wang DM, et al. Effects of recombinant human interferon α-2b gel combined with ALA-PDT on serum T cell subsets, GM-CSF levels and quality of life in patients with condyloma acuminatum[J]. Chinese Sexual Science, 2019, 28(1): 127-131.] DOI: 10.3969/j.issn.1672-1993. 2019.01.038.

5.陈峰, 吴曦, 穆迎涛, 等. 血府逐瘀汤联合常规治疗对急性脑梗死患者炎症反应、氧化应激、内皮及相关因子的影响[J]. 海南医学院学报, 2019, 25(10): 762-765,770. [Chen F, Wu X, Mu YT, et al. Effects of Xuefu Zhuyu decoction combined with conventional therapy on inflammatory response, oxidative stress, endothelium and related factors in patients with acute cerebral infarction[J]. Journal of Hainan Medical University, 2019, 25(10): 762-765,770.] DOI: 10.13210/j. cnki. jhmu.20190327.001.

6.刘莉, 吴敏. 加减血府逐瘀汤治疗子宫肌瘤疗效观察及安全性分析[J]. 四川中医, 2018, 36(1): 154-156. [Liu L, Wu M. Curative observation and safety of using modified Xuefu Zhuyu decoction in the treatment of hysteromyoma[J]. Sichuan Traditional Chinese Medicine, 2018,36(1): 154-156.] DOI: 10.3969/j.issn.1671-2242. 2018.02.072.

7.金星宇, 时广伟. 血府逐瘀汤结合紫杉醇+奈达铂方案对气滞血瘀证宫颈癌患者化疗毒副作用及生存期的影响[J]. 中国性科学, 2023, 32(1): 109-113. [Jin XY, Shi GW. The effect of Xuefu Zhuyu Tang combined with paclitaxel+nedaplatin regimen on chemotherapy toxicity and survival in cervical cancer patients with Qi stagnation and blood stasis syndrome [J]. Chinese Journal of Sexual Science, 2023, 32(1): 109-113.] DOI: 10.3969/j.issn.1672-1993.2023.01.027.

8.郑筱萸. 中药新药临床研究指导原则[M]. 北京: 中国医药科技出版社, 2002: 221.

9.Shi S, Ye Q, Yu C, et al. The efficacy and safety of Xuefu Zhuyu decoction combined with Mifepristone in the treatment of uterine leiomyoma: a systematic review and meta-analysis[J]. Journal of Ethnopharmacology, 2021, 281(1): 114-115. DOI: 10.1016/j. jep.2021.114551.

10.Wang D, Wang P, Zhang R, et al. Efficacy and safety of Xuefu Zhuyu decoction combined with Western medicine for angina pectoris in coronary heart disease: a protocol for systematic review and meta-analysis[J]. Medicine, 2020, 99(50): 195-196. DOI: 10.1097/MD.0000000000023195.

11.Liu C, Guo X. Adjuvant Chinese medicine for the treatment of type 2 diabetes mellitus combined with mild cognitive impairment: a systematic review and Meta-analysis of a randomised controlled trial[J]. Pharmaceuticals, 2022, 15(11): 1424. DOI: 10.3390/ph15111424.

12.黄芳, 李维玲, 陈媛媛, 等. 桂枝茯苓丸和参麦散加减对宫颈癌术后放化疗患者近期疗效、毒副反应及免疫功能的影响[J]. 现代中西医结合杂志, 2019, 28(26): 2928-2931. [Huang F, Li WL, Chen YY, et al. Effects of modified Guizhi Fuling pill and Shenmai powder on short-term efficacy, toxicity, and immune function in patients with postoperative radiotherapy and chemotherapy for cervical cancer [J]. Journal of Modern Integrated Traditional Chinese and Western Medicine, 2019, 28 (26): 2928-2931.] DOI: 10.3969/j.issn.1008-8849.2019.26.020.

13.Yang J, Li J, Deng Q, et al. Effect of neoadjuvant chemotherapy combined with arterial chemoembolization on short-term clinical outcome of locally advanced gastric cancer[J]. BMC cancer, 2023, 23(1): 1-13. DOI: 10.1186/s12885-023-10712-w.

14.蔡卉, 刘艺, 徐静静. 中药八珍汤辅助术后化疗治疗宫颈癌患者的临床疗效及对血清肿瘤坏死因子和免疫球蛋白水平的影响[J]. 世界中西医结合杂志, 2020, 15(12): 2281-2284. [Cai H, Liu Y, Xu JJ. Clinical efficacy of Bazhen Decoction in adjuvant chemotherapy for cervical cancer patients and its effect on serum tumor necrosis factor and immunoglobulin levels[J]. World Journal of Integrated Traditional Chinese and Western Medicine, 2020, 15(12): 2281-2284.] DOI: 10.13935/j.cnki.sjzx.201227.

15.谭忠伦. 血府逐瘀汤联合米非司酮治疗中老年子宫肌瘤的应用疗效及对相关指标的影响[J]. 中国医药导刊, 2019, 21(10): 583-588. [Tan ZL. The therapeutic effect of Xuefu Zhuyu Tang combined with mifepristone in the treatment of middle-aged and elderly uteriane fibroids and its impact on related indicaators[J]. Chinese Medical Journal, 2019, 21(10): 583-588.] DOI: 10.3969/j.issn.1009-0959.2019.10.004.